ID IVD M V VCP Impact assessment of WHO prequalification and systems supporting activities (June 2019) PDF
ID IVD M V VCP Impact assessment of WHO prequalification and systems supporting activities (June 2019) PDF
ID IVD M V VCP Impact assessment of WHO prequalification and systems supporting activities (June 2019) PDF
ID IVD M V VCP Impact assessment of WHO prequalification and systems supporting activities (June 2019) PDF
ID IVD M V VCP Impact assessment of WHO prequalification and systems supporting activities (June 2019) PDF
IVD Information for manufacturers on the inspection of manufacturing sites: Prequalification of male circumcision devices (PQDx_014 V4, Version MC_0, 15 November 2012) PDF
IVD Instructions and requirements for Emergency Use Listing (EUL) submission: In vitro diagnostics detecting antibodies to SARS-CoV-2 virus PDF
IVD Instructions and requirements for Emergency Use Listing (EUL) submission: In vitro diagnostics detecting SARS-CoV-2nucleic acidandrapid diagnostics tests detecting SARS-CoV-2 antigens PDF
IVD Instructions for submission requirements: in vitro diagnostics (IVDs) detecting antibodies to Zika virus (PQDx_239 v4, 28 October 2016) PDF
IVD Instructions for submission requirements: in vitro diagnostics (IVDs) detecting Zika virus nucleic acid or antigen (DxPQ_240 version 3, 24 October 2016) PDF
IVD Instructions for the completion of the pre-submission form for application for prequalification of an in vitro diagnostic PDF
IVD Invitation to manufacturers of in vitro diagnostics for SARS-CoV-2 to submit an application for emergency use listing by WHO PDF